Baxalta
ADYNOVATE
Manufacturer:
Baxalta
Name:
ADYNOVATE
HCPCS Code Descriptor:
Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
Category:
J Code
HCPCS:
J7207
NDC(s):
00944-4627-01, 00944-4628-01, 00944-4626-01, 00944-4625-01, 00944-4624-01, 00944-4622-01, 00944-4623-01
Primary Type:
Hematology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ADYNOVATE is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7207 is aligned to the drug ADYNOVATE.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/17
HCPCS Effective Date:
1/1/17
HCPCS Short Description:
Factor viii pegylated recomb
Billing and Coding Guide:
https://www.shirecontent.com/PDFs/adynovate/ADYNOVATE-Quick-Reference-Coding-Sheet-Digital-R.pdf
Patient Assistance:
https://www.hematologysupport.com/financial-assistance#about-pap